Intellicell Biosciences Inc (fka SVFC)

[gempicker]

Pondering...

The major requirement to proceed with the OA IND with Andrews and Inventive is.... Funding

To even entertain the idea and propose addition INDs for cardio, ALS, Autism requires... Funding

Would any entity(s) looking to fund INDs want to be part of this corporate structure and it's "rich" history... NO

Would any entity(s ) looking to fund INDs want their funds convoluted with an uncertain business model of tissue sampling and license or cryo revenues?... Certainly NO

Hypothesis: in order to move forward with INDs, a JV with exclusive license to extraction method OR a spin off entity must have always been in play and all players with a stake here have always known this.

ICBS research subsidiary was specific for FDA INDs clinical claims. It has always been stated in filings.

Conclusion: the share structure has never really mattered and been that important because the end game has always been a separation of business units... Curiously, it has become important and almost hasty for stakeholders to now convert into a large equity stake.

What would spin off do to share price and how would this create a nice valuation floor under this equity assuming the parent SVFC holds a significant minority interest?